Targeted Prostate Cancer Screening Can Save Men from Unnecessary Cost and Treatment
A research finding from the UK has concluded that thousands of UK men can be saved from unnecessary treatments for prostate cancer if only the screening could be targeted at the age and gene of the patient.
The findings of the research were recently submitted at the NCRI Cancer Conference in Liverpool recently.
The implication of this personalized approach can reduce the cost the NHS incurs on the millions of men having this disease. Details of this research and its findings are highlighted below:
Targeting prostate cancer screening based on a man’s age and genes could potentially save thousands of men from unnecessary treatment and save the NHS millions of pounds. The research is presented at the NCRI Cancer Conference in Liverpool today (Monday).
The researchers, funded by Cancer Research UK, developed a theoretical model to compare the effectiveness and cost of two different approaches to prostate cancer screening.
The model showed that a personalised approach – based on a man’s age and looking for the common genes that increase the risk of prostate cancer – would result in fewer deaths from the disease and cost tens of millions less for the NHS to roll out compared to screening all men aged 55 to 79 every four years with the PSA test.
The model also showed 50 per cent fewer men would need to be screened and 18 per cent fewer men would be diagnosed with the disease – possibly reducing the problem of over-diagnosis and saving men from unnecessary treatment that can lead to side effects like impotence and incontinence. Men in the UK are not screened for prostate cancer as part of a national screening programme.
This is because the only available test, the PSA test, is not an accurate indicator of whether a man does have cancer and cannot reliably tell if a cancer is aggressive and so needs treatment. Instead, men who ask for a PSA test are given information by their GP to help them understand the pros and cons before they decide whether they want to go ahead with the test.
Study author Dr Nora Pashayan, a Cancer Research UK clinician scientist at University College London, said: “We don’t have a screening programme for prostate cancer because the benefits are outweighed by the harms.
Identifying men who are more likely to develop prostate cancer and targeting them for screening could potentially save thousands of men from overdiagnosis and unnecessary treatment. We’re now refining our model to develop more definite predictions which will then need to be tested in trials to see if this approach will have the effect we predict.” Each year over 40,000 men are diagnosed with prostate cancer in the UK, with over 10,500 men dying from the disease.
Professor Peter Johnson, Cancer Research UK’s chief clinician, said: “There is great uncertainty about the usefulness of screening for prostate cancer using the PSA test, with many men finding it difficult to weigh up the pros and cons. This research suggests an important way to select men for whom testing may be more worthwhile, which points us in the right direction for the future. Cancer Research UK is already funding research that is looking at targeting screening to men at a higher risk of developing the disease.” Source.
Conclusively, from the details above, it becomes really necessary that doctors should start thinking of channeling their screening to suit the peculiarity of individuals.
This is very important as it can help to save cost and unnecessary treatments which could cause more harm than good for the individuals.
It’s also important to know that these findings have revealed another useful angle to the latest controversy surrounding the effectiveness of the PSA test in screening men with cancer of the prostate.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- Timely Screening and Health Exams for Prostate Cancer Still Save the Lives of Men
- Prostate Cancer Test – Greenville Men Gets Free Screening
- Prostate Cancer Screening For Middle-Age Men Recommended By a New Study
- Prostate Cancer Screening – The PSA Test and DRE Screening
- How Prostate Cancer Diagnosis Can Save Your Life
- Diagnosis And Treatment Health Prostate Cancer – Early Screening
- Why Prostate Cancer Screening Programs Are Important
- Prostate Cancer Treatment Early Can Save Life And Money
- Prostate Cancer Treatment By Proton Therapy And Cost To Patients
- How Prostate Cancer Charity Organizations Can Save Your Life
- Prostate Cancer Test WILL Save Your Life
- Treatment For End Stage Prostate Cancer That Can Save Your Life
- Are You This Wrong About Prostate Cancer Screening?
- Whats Prostate Cancer Screening and Diagnosis
- Should The New Guidelines For PSA Screening Be Ignored?